Form 4: Danaher SVP Ellis Reports Routine Stock Transactions

Sentiment:

Insider Transaction Report


Danaher's Senior Vice President and General Counsel, Brian W. Ellis, reported the disposition of shares for tax purposes and an acquisition of notional shares in a deferred compensation plan.

Summary

  • Brian W. Ellis, Senior Vice President General Counsel of Danaher Corp (DHR), reported transactions on February 2, 2026.
  • Disposed of 1,254 shares of common stock at a price of $223.42 per share. This transaction was for tax purposes in connection with the distribution of performance-based restricted stock units.
  • Acquired 251 notional shares in the Danaher Deferred Compensation Programs Danaher Stock Fund at a price of $218.89 per notional share. This represents the company's annual contribution to the program.
  • Following these transactions, Ellis directly beneficially owns 13,299 shares of common stock.
  • Ellis also beneficially owns 6,944.632 notional shares in the Danaher Deferred Compensation Programs Danaher Stock Fund.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine insider transactions related to executive compensation and tax obligations, which are not indicative of significant operational or strategic changes.

Positives

  • The acquisition of 251 notional shares in the deferred compensation program indicates continued participation and alignment of the executive with company performance and long-term incentives.

Negatives

  • The disposition of 1,254 shares, although for tax purposes, results in a reduction of direct beneficial ownership of common stock.

Future Outlook

The filing does not provide specific forward-looking statements or guidance beyond the general terms of the deferred compensation program, which are summarized in the company's latest annual meeting proxy statement.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as those reported in Form 4 filings for tax withholding or deferred compensation, are common across industries and typically do not signal significant shifts in company strategy or performance. These transactions reflect standard executive compensation and tax practices.

Comparison to Industry Standards

  • The disposition of shares for tax purposes related to restricted stock units is a standard practice for executives receiving equity compensation across large public companies, comparable to practices at peers like Thermo Fisher Scientific or Abbott Laboratories.
  • The acquisition of notional shares through a company-contributed deferred compensation program is also a common executive retention and incentive tool, aligning with compensation structures seen in other diversified industrial and life sciences companies.

Stakeholder Impact

  • Shareholders: The impact on shareholders is minimal, as these are routine insider transactions related to executive compensation and tax planning, not indicative of changes in company fundamentals or strategy.
  • Employees: No direct impact on the broader employee base beyond the reporting executive.

Next Steps

  • The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission.

Key Dates

DateDescription
02/02/2026Date of earliest transaction, including the disposition of common stock and the acquisition of derivative securities.
02/04/2026Date the Form 4 was signed by the reporting person's attorney-in-fact.

Recommendation

hold

The filing details routine insider transactions for tax purposes and deferred compensation, which do not provide new information to alter an investment thesis. The transactions are expected and do not reflect a change in the company's operational performance or strategic direction, thus a 'hold' recommendation is appropriate.

Keywords

Danaher, DHR, Form 4, Insider Transaction, Executive Compensation, Stock Disposition, Deferred Compensation, Brian W. Ellis

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.